Inflammasome activation at the crux of severe COVID-19
Author:
Publisher
Springer Science and Business Media LLC
Subject
Energy Engineering and Power Technology,Fuel Technology
Link
https://www.nature.com/articles/s41577-021-00588-x.pdf
Reference186 articles.
1. Berlin, D. A., Gulick, R. M. & Martinez, F. J. Severe Covid-19. N. Engl. J. Med. 383, 2451–2460 (2020).
2. Jurado, A. et al. COVID-19: age, interleukin-6, C-reactive protein, and lymphocytes as key clues from a multicentre retrospective study. Immun. Ageing 17, 22 (2020).
3. Argenziano, M. G. et al. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series. BMJ 369, m1996 (2020).
4. Petrilli, C. M. et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ 369, m1966 (2020).
5. Price-Haywood, E. G., Burton, J., Fort, D. & Seoane, L. Hospitalization and mortality among black patients and white patients with Covid-19. N. Engl. J. Med. 382, 2534–2543 (2020).
Cited by 240 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Viral myocarditis: From molecular mechanisms to therapeutic prospects;European Journal of Pharmacology;2024-11
2. Comparative Analysis of Canonical Inflammasome Activation by Flow Cytometry, Imaging Flow Cytometry and High-Content Imaging;Inflammation;2024-09-10
3. Hemostasis correction in the treatment and rehabilitation of COVID-19 patients;Rehabilitology;2024-09-06
4. A Multi-Machine Learning Consensus Model Based on Clinical Features Reveals That Interleukin-10 Derived from Monocytes Leads to a Poor Prognosis in Patients with Coronavirus Disease-2019;Journal of Inflammation Research;2024-09
5. Characterization of a small molecule inhibitor of the NLRP3 inflammasome and its potential use for acute lung injury;Bioorganic Chemistry;2024-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3